Professionals 211 Users Online

Peptone Market

Market Study on Peptones: Demand Rising in Microbiological Research for Development of Biologics & Vaccines

Peptone Market Segmented By Soy Peptone, Vegetable Peptone, Yeast Extract & Peptone and Beef Extract, Casein Peptone, Gelatin Peptone and many more from Plant, Yeast and Animal Source for Protein Hydrolysates, Infusions, Extracts Product

Peptone Market Outlook (2022-2032)

The global peptone market is valued at US$ 142 Mn at present and is projected to expand at a value CAGR of 4.1% to reach a market valuation of US$ 211.3 Mn by 2032.

According to Persistence Market Research, peptones derived from animal sources enjoyed a global market value of US$ 77.5 Mn in 2021, accounting for over 50% of the global peptone market share.

Worldwide sales of peptones accounted for around 2.6% share of the global cell culture media market in 2021.

Attribute Key Insights

Peptone Market Size (2022)

US$ 142 Mn

Projected Market Value (2032)

US$ 211.3 Mn

Global Market Growth Rate (2022-2032)


Share of Top 5 Countries


Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Sales Analysis of Peptones (2017 to 2021) Vs. Market Outlook (2022 to 2032)

The global market for peptones expanded at a CAGR of 3.5% over the last five years (2017-2021).

Peptones are protein derivatives synthesized by partial hydrolysis, also known as protein hydrolysates. They are mostly preferred for bacterial growth in cell culture media optimization in mammalian as well as microbial cell culture processes. Peptones remain to be successfully used for improvement in the production of monoclonal antibodies, biosimilars, and vaccines.

Increasing global burden of chronic diseases associated with changes in lifestyles has been creating a huge demand for new biologics in the microbiology space. Demand for biologics has upheld the focus for microbiology study associated with cell culture media, attracting animal-free peptones that have been fast-tracking the production process of biologics to meet the global demand. Thus, growing focus on novel biologics production is foreseen to transform the biopharmaceutical industry over the coming years.

The global peptone market is predicted to rise at a CAGR rate of 4.1% and record a sales value of US$ 211.3 Mn by the end of 2032.


Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

What Opportunities are on Offer for Peptone Manufacturers?

“Contract Manufacturing Surging in Asia Pacific Region”

Some of the leading biopharmaceutical players in the global market have adopted outsourcing models to expand their market footprint and generate a high rate of interest. Strategic long-term agreements and partnerships with local suppliers help manufacturers lower their operational costs.

Furthermore, peptone manufacturing companies can benefit from better pricing by outsourcing. Moreover, overall run-time, transportation, and logistical costs are reduced to a great extent.

Companies need to capitalize on their resources in Asia Pacific and enter into partnerships with local contract-based manufacturers for long-term sustainable market growth.

“Favorable Government Support for Accelerating Biopharmaceutical Industry Production”

Over the last few years, Asian and Middle Eastern & African government authorities have been encouraging multinational companies as well as start-ups to boost the industrial growth of the healthcare and biopharmaceutical industry. Major players in the biopharmaceutical space are focusing on capitalizing on their economies of scale to strengthen their position in the market.

For instance, developing countries in the Asia Pacific region, such as India, have announced new investment policies for attracting major companies as well as start-up companies across several domains, including the development of biopharmaceuticals using peptones.

Thus, favorable government policies in developing countries are expected to create huge opportunities for companies to invest in the peptone market.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

How is Demand for Peptones being Adversely Affected?

“Risk of Virus Contamination During Cell Culture”

Several commercially-available peptones are used for different cell culture processes as growth supplements. Depending upon the type of cell culture, such as plant, animal, and microbial, different types of peptone supplements are used.

Peptones derived from animal sources or plant sources are used in cell culture optimization as a growth supplement. Some factors such as low quality of the product, lack of ultrafiltration, or mishandling of products in the sterilized area can cause contamination that can affect the quality of media.

In addition, animal-derived peptones possess a high risk of viral contamination during cell culture optimization, which is expected to restrain the growth of the global peptone market to some extent.

“Complexity in Regulatory Approvals for Distributing Services”

Complexity in the regulatory approval process is expected to hinder peptone production to some extent.

Every country has its regulatory authority and approval procedures, while several follow major countries’ authorized regulations such as the United States Food Drug and Administration (US FDA) and European Union (EU). In such circumstances, one supplier cannot present a new updated or improved product until all approvals of their peptones are acknowledged.

Companies need to wait until all regulatory approvals have been received before they begin the distribution of their products. The cost of distributing products in a fragmented manner is large enough that manufacturers need to wait for years to receive all regulatory approvals. Such a scenario is expected to hinder the growth of the peptone market.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Country-wise Insights

How are Peptone Suppliers Strategizing in the U.S. Market?

“Expansion & Increasing Production Capacity by U.S. Companies”

The U.S. accounts for a market share of 81.7% in the North American peptone market.

Increasing prevalence of life-threatening chronic diseases has led the country to account for the highest market share in the North American region. Additionally, the presence of leading players expanding their production capacity and enhancing their manufacturing chain are expected to offer opportunities in the market.

  • For instance, in March 2021, Nu-Tek BioSciences, LLC introduced the first animal-free peptone and protein hydrolysate manufacturing facility in Austin, U.S.

Why is the Peptone Industry Huge in Germany?

“Leading Peptone Manufacturers Present in Germany”

In terms of value, Germany accounts for one-fourth of the European peptone market.

Germany is among the top countries that have a high healthcare expenditure. The country is projected to experience steady growth over the coming years at a growth rate of 2.8%. This market share percentage is because several major players in this industry are active in Germany, which increases the availability of products in the country.

Why is China Emerging as a Prominent Market for Peptones?

“Strategic Activities by Industry Players Present in China”

In 2021, the China peptone market was valued at US$ 8.8 Mn and held a market share of 45.2% in East Asia.

Focusing on the development of healthcare infrastructure and strategic planning to collaborate for expansion are key factors anticipated to have a positive impact on the growth of this industry in China.

The existence of a large number of importers as well as exporters, and increased collaborative research activities, will drive the China market and would offer lucrative opportunities for local manufacturers. China exports active pharmaceutical ingredients, which is expected to accelerate the demand for peptones in the country.

What is the Outlook for the India Peptone Market?

“Rapid Growth of Biotechnology Industry and Research Activities in India”

India accounted for 51.9% of the total value of the South Asia peptone market, valued at US$ 8.2 Mn in 2021. India is among the top 12 destinations for biotechnology worldwide.

The Indian biotechnology market was worth US$ 63 billion in 2019 and is projected to grow to US$ 150 billion by 2025.

  • According to the India Brand Equity Foundation, there are currently 5,000 biotech businesses in the country, of which, 760 are core businesses and 4,240 are start-ups. By 2024, it is anticipated that there will be about 10,000 businesses.

Thus, rapid growth of biotechnology research is expected to drive demand for peptones in India over the coming years.

Category-wise Insights

Which Peptone Source Enjoys Highest Popularity?

“High Demand for Animal-sourced Peptone”

The animal source of peptones accounted for the highest market share of 56.9%, by revenue, in 2021.

Availability of low-cost, diverse products and high adoption of animal-derived peptones for microbial cell culture are leading factors driving the dominance of animal sources.

Peptones derived from plant sources are estimated to hold more than 30% market share and exhibit steady growth during the forecast period.

Which Product Generates High Demand for Peptone Production?

“Protein Hydrolysates Continue to Account for Highest Market Share”

Protein hydrolysates held the highest market share of 76.7% in 2021 and are anticipated to have a dominant stance throughout the forecast period. However, the extracts segment will see significant growth and drive demand in this market at the highest CAGR of 3.9% during the forecast period.

Protein hydrolysates are extensively used as feed and food additives. They consist of a variety of proteins, including soy proteins, whey proteins, caseins, and gelatin.

Where is There High Application of Peptones?

“Microbial Cell Culture Driving Global Demand for Peptone”

Microbial cell culture generated a high market revenue share of more than 60% in the global peptone market, as peptones are extensively used for microbial cell culture growth optimization in the biopharmaceutical industry.

Additionally, increasing research activities, coupled with large-scale microbial fermentation by pharmaceutical and biotechnology industries, have led to the popularity of microbial cell culture applications in the market.

Competitive Landscape

Leading peptone suppliers are engaged in collaborative approaches for the manufacturing and distribution of peptone products through various market consolidation activities. These collaborative approaches between companies are expected to help secure future growth and market position.

In addition, acquisitions and mergers are expected to bolster the research and development of new technologies in bioprocess services. Key manufacturers are focused on approvals, product launches, and acquisitions for gaining high market revenue in the peptone industry.

  • In November 2021, Biotecnica launched a new line of low endotoxin EndoLow peptones that do not require ultrafiltration. EndoLow Peptones are next-generation peptones developed for the production of medications, vaccines, and diagnostic products.
  • In February 2020, Neogen Corporation acquired Abtek Biologicals Ltd., intending to increase its current portfolio. The acquisition was projected to accelerate the growth of Neogen's global microbiology business.

Peptone Industry Report Scope

Attribute Details

Forecast Period


Historical Data Available for


Market Analysis

US$ Million for Value

Key Countries Covered

  • U.S.
  • Canada
  • Brazil
  • Mexico
  • Argentina
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Russia
  • India
  • Thailand
  • Indonesia
  • Malaysia
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • GCC Countries
  • Turkey
  • Northern Africa
  • South Africa

Key Market Segments Covered

  • Source
  • Product
  • Application
  • End User
  • Region

Key Companies Profiled

  • Hi-Media Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Hardy Diagnostics
  • Solabia Group
  • Kerry Inc.
  • Organotechnie
  • Biotecnica
  • Nu-Tek BioScience LLC
  • Tatua
  • Krishna Enzytech Pvt. Ltd.
  • Titan Biotech
  • Suvidhinath Laboratories
  • Jeevan Biotech

Report Coverage

  • Market Forecast
  • Competition Intelligence
  • DROT Analysis
  • Market Dynamics and Challenges
  • Strategic Growth Initiatives

Customization & Pricing

Available upon Request

Key Segments Covered in Peptone Industry Survey

Peptone Market by Source:

  • Plants
    • Soya Peptones
    • Vegetable Peptones
    • Others
  • Yeast
    • Peptone
    • Extract
  • Animal
    • Beef Extract
    • Casein Peptones
    • Gelatin Peptones
    • Brain Heart Infusion (Bovine)
    • Brain Heart Infusion (Porcine)
    • Casein (Acid Hydrolysate)
    • Heart Infusion (Bovine)
    • Heart Infusion (Porcine)
    • Lactalbumin
    • Meat Peptone (Bovine)
    • Meat Peptone (Porcine)
    • Ox-Bile
    • Peptonized Milk
    • Polypeptone
    • Pork Heart Digest
    • Protease Peptones

Peptone Market by Product:

  • Protein Hydrolysates
  • Infusions
  • Extracts

Peptone Market by Application:

  • Microbial Cell Culture
  • Mammalian Cell Culture
  • Plant Tissue Culture
  • Yeast Culture

Peptone Market by End User:

  • Academic & Research Institutes
  • Biopharmaceutical Companies
  • Contract Research Laboratories

Peptone Market by Region:

  • North America Peptone Market
  • Latin America Peptone Market
  • Europe Peptone Market
  • South Asia Peptone Market
  • East Asia Peptone Market
  • Oceania Peptone Market
  • The Middle East & Africa (MEA) Peptone Market

- Companies Covered in This Report -

  • HiMedia Laboratories
  • Thermo Fisher Scientific, Inc
  • Merck KGaA
  • Hardy Diagnostics
  • Solabia Group
  • Kerry Inc
  • Organotechnie
  • Biotecnica
  • Nu-Tek BioScience LLC
  • Tatua
  • Krishna Enzytech Pvt. Ltd
  • Titan Biotech
  • Suvidhinath Laboratories
  • Jeevan Biotech

- Frequently Asked Questions -

The global peptone market is valued at US$ 142 Mn in 2022 and is expected to grow 1.5X by 2032.

The peptone industry is set to exhibit 4.1% CAGR and be valued at US$ 211.3 Mn by 2032.

Sales of peptones increased at 3.5% CAGR between 2017 and 2021.

Increasing manufacturing facility expansion activities, research focus on bioprocessing, strategic collaboration, acquisitions, and production capacity expansion are key trends shaping the global peptone industry.

Protein hydrolysates account for high demand and held around 76.7% market share in 2021.

The U.S., Germany, China, India, and Japan account for the highest demand for peptones.

The U.S. is expected to account for 80.1% of the North American market share by 2032.

The Europe market for peptones is expected to record a CAGR value of 3.6% over the decade.

The U.S., Canada, Germany, France, and Japan are major producers of peptone products.

China held a share of 45.2% in the East Asia peptone market in 2021, while India accounted for 51.9% of the South Asia market share.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate